The new webinar by our partner Gattefossé:
This webinar will explore how Self-Emulsifying Drug Delivery Systems (SEDDS) and other lipid-based formulations are shaping the future of life cycle management (LCM) and age-appropriate drug design. Through the 505(b)(2) regulatory pathway, reformulation strategies can enhance bioavailability, mitigate food effects, and enable oral delivery of challenging molecules such as peptides and testosterone. Case studies will illustrate the clinical and commercial impact of lipid-based drug delivery systems.
The session will also address pediatric formulation challenges, focusing on excipient safety, taste masking, and flexible dosing enabled by structured lipids such as Compritol®, Precirol®, and Gelucire®. Attendees will gain insights into how lipid excipients and SEDDS technologies can drive innovation across therapeutic generations—delivering safer, more effective, and patient-friendly medicines from adults to children.
Key Takeaways:
- See how lipid-based formulations are driving innovation in life cycle management and age-appropriate design
- Learn how lipid benefits enable next-generation, patient-friendly 505(b)(2) formulations
- Address pediatric challenges in safety, taste masking, and flexible dosing
- Explore real-world case studies showcasing clinical and commercial success
Date: Wed, Dec 3, 2025 5:00 PM
Time: 6:00 PM CET
Timezone: Amsterdam, Berlin, Rome, Stockholm, Vienna
Speaker:

Johan Arango
Inside Technical Sales Representative
Gattefossé USA
For more information & registration here:
Source: Gattefossé, website Lipid Formulations Across Generations: Lifecycle Management for Adult and Pediatric Populations, https://www.gattefosse.com/news/lipid-formulations-across-generations-lifecycle-management-adult-and-pediatric-populations

















































